EPCAM and hepatocellular carcinoma: In addition, since EpCAM has been identified as a surface marker of HCC cells displaying stem cell features [80,81] and EpCAM+ CTCs from HCC patients are highly tumorigenic in vivo [60], it is possible that EpCAM+ CTCs account for both tumorigenic and non-tumorigenic cells.